Why It Matters
The company filed its second-quarter lobbying disclosure for $330,000, continuing a pattern from recent quarters. The general areas of interest include consumer issues/safety, pharmacy, and taxation.
By the Numbers
Walgreens filed $330,000 in lobbying expenditures July 27. Madeline Hodge served as the sole in-house lobbyist listed, representing a change from earlier quarters when Isaac Fordjour also appeared on the roster. Hodge has been a consistent in-house presence throughout the past year.
On the external front, Walgreens engaged Ballard Partners LLC, Forbes Tate Partners LLC, BGR Government Affairs LLC, GuidePostStrategies LLC, and S-3 Group LLC.
Spending remained flat compared to the first quarter of 2026, when the company also reported $330,000 though in-house expenditures. That represented a decrease from the fourth quarter of 2025, which totaled $450,000.
Broader Context
Walgreens' recent lobbying history reveals focus on several legislative priorities. The company has consistently lobbied on the Combating Organized Retail Crime Act, which would establish a federal coordination center to address organized theft rings. Walgreens, Target, and Kroger have urged swift passage, citing increased violence, losses, and urgent holiday-season threats.
The 2026 Consolidated Appropriations Act included sweeping pharmacy benefit manager reforms and earmarked $321 million in federal funding to lower drug costs and increase price transparency.
The Bottom Line
Walgreens continues legislative advocacy at a consistent spending level. The company maintains both in-house and external lobbying capacity as it navigates ongoing changes to pharmacy regulation and retail operations.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article